BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Hepatol Commun 2019;3:20-8. [PMID: 30619991 DOI: 10.1002/hep4.1282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Squires JE, Balistreri WF. Treatment of Hepatitis C: A New Paradigm toward Viral Eradication. The Journal of Pediatrics 2020;221:12-22.e1. [DOI: 10.1016/j.jpeds.2020.02.082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Freriksen JJM, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R, Russel FGM, Drenth JPH, Colbers A, Burger DM. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment Pharmacol Ther. 2019;50:738-750. [PMID: 31448450 DOI: 10.1111/apt.15476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
3 Dugan E, Blach S, Biondi M, Cai Z, DePaola M, Estes C, Feld J, Gamkrelidze I, Kottilil S, Ma S, Mathur P, Montoya S, Razavi-Shearer D, Razavi-Shearer K, Robbins-Scott S, Schmelzer J, Razavi H. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study. Lancet Gastroenterol Hepatol 2021;6:169-84. [PMID: 33515496 DOI: 10.1016/S2468-1253(20)30359-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kushner T, Djerboua M, Biondi MJ, Feld JJ, Terrault N, Flemming JA. Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.05.016] [Reference Citation Analysis]
5 Judd A, Collins IJ, Pett S, Gibb DM. Labour pains: eliminating HCV in women and children. Lancet Gastroenterol Hepatol 2021;6:150-1. [PMID: 33515495 DOI: 10.1016/S2468-1253(20)30373-3] [Reference Citation Analysis]
6 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martínez-Espinosa FE. [Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis]. Epidemiol Serv Saude 2021;30:e2020834. [PMID: 33729415 DOI: 10.1590/S1679-4974202100016.esp1] [Reference Citation Analysis]
7 Gross MS, Ruth AR, Rasmussen SA. Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy. J Med Ethics 2020;46:674-7. [PMID: 32054774 DOI: 10.1136/medethics-2019-105692] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Pearce ME, Yu A, Alvarez M, Bartlett SR, Binka M, Jeong D, Clementi E, Adu P, Wilton J, Yoshida EM, Pick N, Buxton JA, Wong J, Jassem A, Krajden M, Janjua NZ. Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019. PLoS One 2020;15:e0244575. [PMID: 33382774 DOI: 10.1371/journal.pone.0244575] [Reference Citation Analysis]
9 Freriksen JJM, Meijerhof M, van Drongelen J, Drenth JPH, Burger DM, Russel FGM, Colbers A, Greupink R. Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivo. Am J Obstet Gynecol 2020;223:941-3. [PMID: 32877661 DOI: 10.1016/j.ajog.2020.08.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Faure-Bardon V, Ville Y. Maternal infections: revisiting the need for screening in pregnancy. BJOG 2021;128:304-15. [PMID: 32937015 DOI: 10.1111/1471-0528.16509] [Reference Citation Analysis]
11 Park H, Song HJ, Jiang X, Henry L, Cook RL, Nelson DR. Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C. Hepatol Commun 2021;5:203-16. [PMID: 33553969 DOI: 10.1002/hep4.1634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pozza R, McCoy-Hill C, Hall K, Hefner A, Wilgers K, Tapelband J, Masroor M, Hassanein T. Eradicating hepatitis C virus: The APRN's role. Nurse Pract 2019;44:16-27. [PMID: 31567700 DOI: 10.1097/01.NPR.0000586008.23422.2c] [Reference Citation Analysis]
13 Kulkarni AV, Duvvuru NR. Management of hepatitis B and C in special population. World J Gastroenterol 2021; 27(40): 6861-6873 [PMID: 34790011 DOI: 10.3748/wjg.v27.i40.6861] [Reference Citation Analysis]
14 Kislovskiy Y, Chappell C, Flaherty E, Hamm ME, Cameron FA, Krans EE, Chang JC. Experiences and Perspectives From Women Taking Investigational Therapy for Hepatitis C Virus During Pregnancy. Subst Abuse 2021;15:11782218211046261. [PMID: 34602820 DOI: 10.1177/11782218211046261] [Reference Citation Analysis]
15 Farshadpour F, Taherkhani R, Bakhtiari F. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. Biomed Res Int 2021;2021:9294276. [PMID: 34589552 DOI: 10.1155/2021/9294276] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chappell CA, Jonas MM. Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat? J Infect Dis 2020;222:S789-93. [PMID: 33245353 DOI: 10.1093/infdis/jiaa181] [Reference Citation Analysis]
17 Leung DH, Squires JE, Jhaveri R, Kerkar N, Lin CH, Mohan P, Murray KF, Gonzalez-Peralta RP, Roberts EA, Sundaram SS. Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020;71:407-417. [PMID: 32826718 DOI: 10.1097/mpg.0000000000002814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Dokmak A, Trivedi HD, Bonder A, Wolf J. Pregnancy in Chronic Liver Disease: Before and After Transplantation. Ann Hepatol 2021;:100557. [PMID: 34656772 DOI: 10.1016/j.aohep.2021.100557] [Reference Citation Analysis]
19 Mostafa A, Ebeid FSE, Khaled B, Ahmed RHM, El-Sayed MH. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies. Trop Med Int Health 2020;25:850-60. [PMID: 32306545 DOI: 10.1111/tmi.13404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martinez-Espinosa FE. Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis. Rev Soc Bras Med Trop 2021;54:e2020834. [PMID: 34008732 DOI: 10.1590/0037-8682-834-2020] [Reference Citation Analysis]
21 Pearce ME, Bartlett SR, Yu A, Lamb J, Reitz C, Wong S, Alvarez M, Binka M, Velásquez Garcia H, Jeong D, Clementi E, Adu P, Samji H, Wong J, Buxton J, Yoshida E, Elwood C, Sauve L, Pick N, Krajden M, Janjua NZ. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study. BMC Womens Health 2021;21:330. [PMID: 34511082 DOI: 10.1186/s12905-021-01470-7] [Reference Citation Analysis]
22 Li J, Casey JL, Greenwald ZR, Yasseen Iii AS, Dickie M, Feld JJ, Cooper CL, Crawley AM. The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination. CanLivJ 2021;4:59-71. [DOI: 10.3138/canlivj-2020-0026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kim NJ, Holguin D, Bush D, Khalili M. Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women. Hepatol Commun 2019;3:1183-90. [PMID: 31497740 DOI: 10.1002/hep4.1401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]